-
Product Insights
Cutaneous Mycosis - Drugs In Development, 2024
Empower your strategies with our Cutaneous Mycosis – Drugs In Development, 2024 report and make more profitable business decisions. Cutaneous mycoses are a group of superficial fungal infections that affect the skin, hair, and nails. They are also known as superficial mycoses. They are confined to the outer layers of the skin, hair, or nails. They rarely invade deeper tissues or viscera, and do not induce a cellular response from the host. Most cutaneous mycoses are caused by dermatophytes, a group...
-
Product Insights
Measles - Drugs In Development, 2024
Empower your strategies with our Measles – Drugs In Development, 2024 report and make more profitable business decisions. Measles is a highly infectious viral disease. The virus lives in the mucus of the nose and throat of people with this infection. Physical contact, coughing, and sneezing can spread the infection. Symptoms of measles are high temperature, sore eyes (conjunctivitis), and a runny nose, which usually occur first; small white spots usually develop inside the mouth a day or so later, with...
-
Product Insights
Onychomycosis (Tinea Unguium) - Drugs In Development, 2024
Empower your strategies with our Onychomycosis (Tinea Unguium) – Drugs In Development, 2024 report and make more profitable business decisions. Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail, and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and surgery. The Onychomycosis (Tinea Unguium) drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
Hand, Foot and Mouth Disease - Drugs In Development, 2024
Empower your strategies with our Hand, Foot and Mouth Disease – Drugs In Development, 2024 report and make more profitable business decisions. Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue....
-
Product Insights
Herpes Labialis (Oral Herpes) - Drugs In Development, 2024
Empower your strategies with our Herpes Labialis (Oral Herpes) – Drugs In Development, 2024 report and make more profitable business decisions. Oral herpes is an infection of the lips, mouth, or gums by the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands, and painful swallowing. Treatment includes antiviral medications. The Herpes Labialis (Oral Herpes) drugs in development market research report provide comprehensive information on the therapeutics under development for Herpes Labialis (Oral...
-
Product Insights
Hepatitis E - Drugs In Development, 2024
Empower your strategies with our Hepatitis E – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis E is a viral infection that causes liver inflammation and damage. Inflammation is swelling that occurs when tissues of the body become injured or infected. Inflammation can damage organs. It is caused by the hepatitis E virus (HEV). The virus has at least 4 different types: genotypes 1, 2, 3 and 4. Genotypes 1 and 2 have been found only in...
-
Product Insights
Tinea Pedis (Athlete Foot) - Drugs In Development, 2024
Empower your strategies with our Tinea Pedis (Athlete Foot) – Drugs In Development, 2024 report and make more profitable business decisions. Athlete's foot, also known as tinea pedis, is a common foot infection caused by fungi called dermatophytes. Symptoms include dry flaking skin on the soles of the feet, unpleasant foot odor, and small itchy bubbles or blisters on the soles of the feet. Treatment includes antifungal medicines. The Tinea Pedis (Athlete Foot) drugs in development market research report provide comprehensive...
-
Product Insights
Botulism - Drugs In Development, 2024
Empower your strategies with our Botulism – Drugs In Development, 2024 report and make more profitable business decisions. Botulism is a rare but serious illness. The cause is a toxin made by a bacterium called Clostridium botulinum. It occurs naturally in soil. Food-borne botulism comes from eating foods contaminated with the toxin. Symptoms include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing, dry mouth, and muscle weakness. Treatment may include antitoxins, intensive medical care, or surgery of infected wounds....
-
Product Insights
Cryptococcal Meningitis - Drugs In Development, 2024
Empower your strategies with our Cryptococcal Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Cryptococcal meningitis is a fungal infection of the meninges, the tissues that cover the brain and spinal cord. The infection is caused by the fungus Cryptococcus, which spreads from the lungs to the brain. Symptoms include headache, fever, confusion, cough, achy chest, rash. Definitive diagnosis of cryptococcal meningitis is made by culture from the CSF. Antifungal agents for the treatment of cryptococcal...
-
Product Insights
Fungal Meningitis - Drugs In Development, 2024
Empower your strategies with our Fungal Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Fungal meningitis a rare, non-contagious, life-threatening fungal infection that causes swelling of the areas around the brain and spinal cord. It is caused due to breathing in fungal spores. The infection can spread from the lungs to the brain or spinal cord. Candida albicans and Cryptococcus neoformans are the most common fungi responsible for meningitis. Symptoms include fever, headache, stiff neck, light...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.